(1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritis
about
(+)-Vitisin A inhibits osteoclast differentiation by preventing TRAF6 ubiquitination and TRAF6-TAK1 formation to suppress NFATc1 activationMolecular Design, Synthesis and Trypanocidal Activity of Dipeptidyl Nitriles as Cruzain InhibitorsAnti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitorsInsights from molecular modeling into the selective inhibition of cathepsin S by its inhibitor.A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin KStructural requirements for the collagenase and elastase activity of cathepsin K and its selective inhibition by an exosite inhibitor.Highly selective aza-nitrile inhibitors for cathepsin K, structural optimization and molecular modeling.Discovery of a novel allosteric inhibitor scaffold for polyadenosine-diphosphate-ribose polymerase 14 (PARP14) macrodomain 2.Advances in the discovery of cathepsin K inhibitors on bone resorption.
P2860
Q35099825-28982E40-37CC-4813-ABD4-C5B3D63880BCQ35691038-460D5AD1-75D6-4003-A318-A9E855C9A131Q36286306-778D3E09-ED6E-42FC-8DA9-08F438361972Q38943054-080CCCAA-8460-4B95-B7B7-B30ED9F0E431Q41771681-31CD1838-ED2A-4353-A985-E5CECF519662Q42686277-05026A9E-C01C-4DCF-B454-0E5509F0A914Q47896150-94450BD4-4530-423E-AE40-28302B425436Q52642106-B6EF66D1-9324-4F83-AE5B-39AB1D0112B7Q55645981-64B984E2-F143-429A-93CF-2388E3FAF76C
P2860
(1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritis
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
(1R,2R)-N-(1-cyanocyclopropyl) ...... he treatment of osteoarthritis
@ast
(1R,2R)-N-(1-cyanocyclopropyl) ...... he treatment of osteoarthritis
@en
(1R,2R)-N-(1-cyanocyclopropyl) ...... he treatment of osteoarthritis
@nl
type
label
(1R,2R)-N-(1-cyanocyclopropyl) ...... he treatment of osteoarthritis
@ast
(1R,2R)-N-(1-cyanocyclopropyl) ...... he treatment of osteoarthritis
@en
(1R,2R)-N-(1-cyanocyclopropyl) ...... he treatment of osteoarthritis
@nl
prefLabel
(1R,2R)-N-(1-cyanocyclopropyl) ...... he treatment of osteoarthritis
@ast
(1R,2R)-N-(1-cyanocyclopropyl) ...... he treatment of osteoarthritis
@en
(1R,2R)-N-(1-cyanocyclopropyl) ...... he treatment of osteoarthritis
@nl
P2093
P356
P1476
(1R,2R)-N-(1-cyanocyclopropyl) ...... he treatment of osteoarthritis
@en
P2093
Adrian J Highton
Alexander G Dossetter
Andrew D Morley
Anja Jestel
Calum R Cook
Caroline Smith
Christine Heyes
Helen Sawney
Howard Beeley
James J Crawford
P304
P356
10.1021/JM3007257
P407
P577
2012-07-26T00:00:00Z